Skip to search formSkip to main contentSkip to account menu

Intraglobin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Immunoglobulins, Intravenous

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Multicenter Crossover Comparison of the Safety and Efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in Patients with Primary Immunodeficiency Diseases
The safety and clinical efficacy of a liquid, β-propiolactone-stabilized intravenous γ-globulin, Intraglobin-F, was evaluated in… 
2000
2000
Intravenous gamma globulin for treatment of chronic idiopathic thrombocytopenic purpura in children.
A prospective and descriptive study was carried out in 17 children with chronic ITP. Five-day course of Intraglobin (400 mg/kg/d… 
1992
1992
CMV prophylaxis after renal transplantation with immunoglobulin or CMV-hyperimmunoglobulin--a prospective clinical trial.
Three groups of 40 patients each entered this prospective randomized trial. Patients of group A received 2 ml/kg body weight CMV… 
1989
1989
Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia.
A prospective, randomized, cross-over study was performed to evaluate the safety and clinical efficacy of an immunoglobulin… 
Review
1989
Review
1989
[Successful therapeutic use of intraglobin-F in idiopathic immuno-thrombopenia, refractory to corticosteroid and immunosuppressive therapy as well as to splenectomy].
The authors present the case of a 21-year old woman patient who was admitted to hospital because of typical symptoms of chronic… 
1984
1984
Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage.
1983
1983
Reversal of acute vascular rejection by plasma exchange.
The vast majority of grafts with acute vascular rejection (AVR) undergo irreversible loss of function, since this type of… 
1981
1981
On the mutagenicity and immunogenicity of a beta-propiolactone-treated therapeutic IgG-preparation.
During the production of Intraglobin, an i.v. tolerable IgG-immunoglobulin preparation, fraction Cohn II is treated with beta… 
1980
1980
Die Anwendung von Intraglobin bei multipler Sklerose (MS) Vorläufiges Ergebnis nach einjähriger Behandlungszeit
Die Haufigkeit der MS — in Mitteleuropa wird sie mit 3–7 Erkrankungen auf 10000 Einwohner angegeben — bedingt die Notwendikteit… 
1973
1973
Antikörpertiter nach intravenöser Gammaglobulintherapie
SummaryThe half-life of intravenous gamma globulin (Intraglobin®, Biotest-Frankfurt) was measured in a child with antibody… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)